Ultimately, the interview underscores a critical transition period for the industry. While tariffs present a unique hurdle ...

Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...

Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...

With a potential US government shutdown looming, Megha Sinha, Kamet Consulting, says to treat FDA disruptions as predictable ...

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

The CDA-200 Dual Shaft Mixer efficiently processes high-viscosity formulations with dual agitators, ensuring uniform mixing and dispersion. Contamination risks are minimized with no submerged bearings ...

Government shutdowns lead to decreased predictability, causing delays in new submissions and manufacturing changes. Key risk ...

HanchorBio and WuXi Biologics collaborate to develop fusion proteins using the Fc-Based Designer Biologics platform, ...

Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...

MASH affects over 250 million globally, with advanced cases expected to double by 2030 due to underlying conditions like obesity and metabolic syndrome. Recent FDA and EMA approvals of Rezdiffra and ...

February 11 is the International Day of Women and Girls in Science (1). This day focuses on the gender gap in science, ...

Mirum Pharmaceuticals acquires Bluejay Therapeutics, focusing on brelovitug for chronic hepatitis delta virus (HDV), a severe ...